Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer’s disease

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Acta Neuropathologica

• Publication date

  2016-05-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00401-016-1580-yPMID 27179972PMCID PMC4947445
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vascular basement membranes as pathways for the passage of fluid into and out of the brain

  2016cited by this paper
• Lymphatic Clearance of the Brain: Perivascular, Paravascular and Significance for Neurodegenerative Diseases

  2016cited by this paper
• Cerebral Amyloid Angiopathy, Subcortical White Matter Disease and Dementia: Literature Review and Study in OPTIMA

  2015cited by this paper
• 2015 Alzheimer's disease facts and figures

  2015cited by this paper
• Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease.

  2014cited by this paper
• Outcome markers for clinical trials in cerebral amyloid angiopathy.

  2014cited by this paper
• Sex modifies the APOE‐related risk of developing Alzheimer disease

  2014cited by this paper
• Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease.

  2014cited by this paper
• Brain regional correlation of amyloid-β with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-β accumulation

  2013cited by this paper
• Cerebral Amyloidal Angiopathy--a disease with implications for neurology and psychiatry.

  2013cited by this paper
• Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease.

  2013cited by this paper
• 2013 Alzheimer's disease facts and figures

  2013cited by this paper
• Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

  2013cited by this paper
• APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in cerebral vasculature.

  2013cited by this paper
• Geographic and Sex Difference in the Distribution of Intracranial Atherosclerosis in China

  2013cited by this paper
• APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis

  2013cited by this paper
• Turning point: Mark Lawrence

  2012cited by this paper
• Apolipoprotein E controls cerebrovascular integrity via cyclophilin A

  2012cited by this paper
• Sex and Gender Differences in Alzheimer's Disease: Recommendations for Future Research

  2012cited by this paper
• Alzheimer mechanisms and therapeutic strategies.

  2012cited by this paper
• Structural basis of C-terminal β-amyloid peptide binding by the antibody ponezumab for the treatment of Alzheimer's disease.

  2012cited by this paper
• Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.

  2011cited by this paper
• Differential effects of the APOE genotype on brain function across the lifespan

  2011cited by this paper
• APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging.

  2010cited by this paper
• Cerebral Microinfarcts Associated with Severe Cerebral β‐Amyloid Angiopathy

  2010cited by this paper
• Variants at APOE influence risk of deep and lobar intracerebral hemorrhage

  2010cited by this paper
• Capillary cerebral amyloid angiopathy identifies a distinct APOE ε4-associated subtype of sporadic Alzheimer’s disease

  2010cited by this paper
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes

  2009cited by this paper
• Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

  2009cited by this paper
• Gender Differences in Stroke Incidence and Poststroke Disability in the Framingham Heart Study

  2009cited by this paper
• Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer

  2009cited by this paper
• Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

  2009cited by this paper
• Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease

  2009cited by this paper
• Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease.

  2008cited by this paper
• SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Perivascular Drainage of Amyloid‐β Peptides from the Brain and Its Failure in Cerebral Amyloid Angiopathy and Alzheimer's Disease

  2007cited by this paper
• Clinical phenotypes of Cerebral Amyloid Angiopathy.

  2007cited by this paper
• Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models.

  2006cited by this paper
• Mechanism of Cerebral β‐Amyloid Angiopathy: Murine and Cellular Models

  2006cited by this paper
• Influence of sex steroid hormones on cerebrovascular function.

  2006cited by this paper
• Sex differences in the clinical manifestations of Alzheimer disease pathology.

  2005cited by this paper
• Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms

  2005cited by this paper
• Human Apolipoprotein E4 Alters the Amyloid-β 40:42 Ratio and Promotes the Formation of Cerebral Amyloid Angiopathy in an Amyloid Precursor Protein Transgenic Model

  2005cited by this paper
• The Biphasic Relationship between Regional Brain Senile Plaque and Neurofibrillary Tangle Distributions: Modification by Age, Sex, and APOE Polymorphism

  2004cited by this paper
• Cerebral Amyloid Angiopathies: A Pathologic, Biochemical, and Genetic View

  2003cited by this paper
• Pathogenesis of cerebral amyloid angiopathy.

  2003cited by this paper
• Alzheimer Disease as a Vascular Disorder: Nosological Evidence

  2002cited by this paper
• Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease.

  2002cited by this paper
• High frequency of apolipoprotein E ϵ2 Allele in hemorrhage due to cerebral amyloid angiopathy

  1997cited by this paper
• Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease

  1996cited by this paper
• Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain

  1995cited by this paper
• Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).

  1995cited by this paper
• High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy.

  1994cited by this paper
• Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease.

  1993cited by this paper
• Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.

  1993cited by this paper
• Cerebral amyloid angiopathy. A critical review.

  1987cited by this paper
• Cerebral Amyloid Angiopathy: The Vascular Pathology and Complications

  1986cited by this paper
• Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes.

  1983cited by this paper

• Multi-functional role of apolipoprotein E in neurodegenerative diseases

  2025cites this paper
• Sleep-Wake Transitions Are Impaired in the AppNL-G-F Mouse Model of Early Onset Alzheimer’s Disease

  2025cites this paper
• Post‐Translational Modifications Distinguish Amyloid‐β Isoforms in Cerebral Amyloid Angiopathy and Alzheimer's Disease

  2025cites this paper
• Decoding Blood-Brain Barrier Dysfunction in Alzheimer's Disease: Innovations and Challenges in Multimodal MRI and PET Imaging Biomarkers.

  2025cites this paper
• Molecular biomarkers for intracerebral hemorrhage: bridging pathophysiology and precision medicines.

  2025cites this paper
• DKK3-LRP1 complex and a chemical inhibitor regulate Aβ clearance in models of Alzheimer’s disease

  2025cites this paper
• Impact of APOE on cerebrovascular lipid profile in Alzheimer’s disease

  2025cites this paper
• Cerebral amyloid angiopathy: a narrative review

  2025cites this paper
• AAV-based temporal APOE4-to-APOE2 replacement reveals rebound adaptation and RAB24-mediated Aβ and cholesterol dysregulation

  2025cites this paper
• Age-related cerebral amyloid angiopathy accumulation in the APPSw mouse model is associated with perivascular inflammation and brain-wide vascular and inflammatory gene and protein changes.

  2025cites this paper
• Tau depletion diminishes vascular amyloid‐related deficits in a mouse model of cerebral amyloid angiopathy

  2025cites this paper
• APOE-ε4 Modulates Facial Neuromuscular Activity in Nondemented Adults: Toward Sensitive Speech-Based Diagnostics for AD

  2025cites this paper
• Neuropsychiatric symptoms and apolipoprotein E genotypes in neurocognitive disorders

  2025cites this paper
• The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: The aberrant pericyte is a central player

  2025cites this paper
• Sex differences in age-associated neurological diseases—A roadmap for reliable and high-yield research

  2025cites this paper
• Sex Differences in Markers of Cerebral Small Vessel Disease in Patients with Lobar Intracerebral Hemorrhage

  2025cites this paper
• Meningeal vascular Aβ deposition associates with cerebral hypoperfusion and compensatory collateral remodeling

  2025cites this paper
• Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer’s disease

  2024cites this paper
• The Emerging Role of PCSK9 in the Pathogenesis of Alzheimer’s Disease: A Possible Target for the Disease Treatment

  2024cites this paper
• Cerebral amyloid angiopathy impacts neurofibrillary tangle burden and cognition

  2024cites this paper
• GWAS of multiple neuropathology endophenotypes identifies new risk loci and provides insights into the genetic risk of dementia

  2024cites this paper
• APOLLOE4 Phase 3 study of oral ALZ‐801/valiltramiprosate in APOE ε4/ε4 homozygotes with early Alzheimer's disease: Trial design and baseline characteristics

  2024cites this paper
• Late-Life Blood Pressure and Cerebral Amyloid Angiopathy: Findings from the U.S. National Alzheimer’s Coordinating Center Uniform Dataset

  2024cites this paper
• The duality of amyloid-β: its role in normal and Alzheimer’s disease states

  2024cites this paper
• Prevalence of Cerebral Amyloid Angiopathy Pathology and Strictly Lobar Microbleeds in East-Asian Versus Western Populations: A Systematic Review and Meta-Analysis

  2024cites this paper
• Sex differences in histopathological markers of cerebral amyloid angiopathy and related hemorrhage

  2024influential citation
• Constitutive NOS Production Is Modulated by Alzheimer’s Disease Pathology Depending on APOE Genotype

  2024cites this paper
• Association between plasma CTRPs with cognitive impairment and neurodegeneration of Alzheimer's disease

  2024cites this paper
• Relationship of APOE with Alzheimer's Disease and Other Neurological Disorders: An Updated Review.

  2023cites this paper
• Lecanemab: More Questions Than Answers!

  2023cites this paper
• Increased tau expression in the APOE4 blood-brain barrier model is associated with reduced anti-tau therapeutic antibody delivery in vitro

  2023cites this paper
• Sex modifies effects of imaging and CSF biomarkers on cognitive and functional outcomes: a study of Alzheimer's disease.

  2023cites this paper
• The role of genetics and gender specific differences in neurodegenerative disorders: Insights from molecular and immune landscape.

  2023cites this paper
• Inhibitor of DNA Binding Protein 3 (ID3) and Nuclear Respiratory Factor 1 (NRF1) Mediated Transcriptional Gene Signatures are Associated with the Severity of Cerebral Amyloid Angiopathy

  2023cites this paper
• Apolipoprotein E in lipid metabolism and neurodegenerative disease.

  2023cites this paper
• Sex-Specific Patterns of Cerebral Atrophy and Enlarged Perivascular Spaces in Patients with Cerebral Amyloid Angiopathy and Dementia

  2023cites this paper
• Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer’s Disease

  2023cites this paper
• White matter hyperintensity volume modifies the association between CSF vascular inflammatory biomarkers and regional FDG-PET along the Alzheimer's disease continuum.

  2023cites this paper
• Leading mediators of sex differences in the incidence of dementia in community-dwelling adults in the UK Biobank: a retrospective cohort study

  2023cites this paper
• Molecular basis of the association between transcription regulators nuclear respiratory factor 1 and inhibitor of DNA binding protein 3 and the development of microvascular lesions.

  2022cites this paper
• Multifocal Cerebral Microinfarcts Modulate Early Alzheimer’s Disease Pathology in a Sex-Dependent Manner

  2022cites this paper
• Neuropsychiatric Inventory–Questionnaire Assessed Nighttime Behaviors in Cognitively Asymptomatic Patients with Pathologically Confirmed Alzheimer’s Disease Predict More Rapid Cognitive Deterioration

  2022cites this paper
• Plasma β-Amyloid, Total-Tau, and Neurofilament Light Chain Levels and the Risk of Stroke

  2022cites this paper
• ApoE Cascade Hypothesis in the pathogenesis of Alzheimer's disease and related dementias.

  2022cites this paper
• APOE ε4, Alzheimer’s disease neuropathology and sleep disturbance, in individuals with and without dementia

  2022cites this paper
• Cerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions

  2022cites this paper
• Claudin-5 relieves cognitive decline in Alzheimer’s disease mice through suppression of inhibitory GABAergic neurotransmission

  2022cites this paper
• Vascular Dysfunction Is Central to Alzheimer’s Disease Pathogenesis in APOE e4 Carriers

  2022cites this paper
• Apolipoprotein E Genotype e2: Neuroprotection and Its Limits

  2022cites this paper
• Missing apolipoprotein E ɛ4 allele associated with nonamnestic Alzheimer’s disease in a Tunisian population

  2022cites this paper
• Influence of Gender on Tau Precipitation in Alzheimer’s Disease According to ATN Research Framework

  2022cites this paper
• Factors associated with the location of perivascular space enlargement in middle-aged individuals undergoing brain screening in Japan.

  2022cites this paper
• Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer’s disease

  2021cites this paper
• Sex differences in a murine model of Cerebral Amyloid Angiopathy

  2021cites this paper
• APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia

  2021cites this paper
• Alzheimer’s pathogenic mechanisms and underlying sex difference

  2021influential citation
• Engineered models for studying blood-brain-barrier-associated brain physiology and pathology

  2021cites this paper
• Cholesterol Dysmetabolism in Alzheimer’s Disease: A Starring Role for Astrocytes?

  2021cites this paper
• EXAMINING HUMAN APOE GENOTYPE AND SEX AS MODULATORS OF RESPIRATORY PLASTICITY IN THE PRESENCE AND ABSENCE OF SPINAL CORD INJURY

  2021cites this paper
• From beta amyloid to altered proteostasis in Alzheimer's disease.

  2020cites this paper
• ApoE4 Astrocytes Secrete Basement Membranes Rich in Fibronectin and Poor in Laminin Compared to ApoE3 Astrocytes

  2020cites this paper
• Reconstruction of the human blood–brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes

  2020cites this paper
• Interactions between Amyloid-Β Proteins and Human Brain Pericytes: Implications for the Pathobiology of Alzheimer’s Disease

  2020cites this paper
• Interactions between Amyloid-Β Proteins and Human Brain Pericytes: Implications for the Pathobiology of Alzheimer’s Disease

  2020cites this paper
• APOE4 exacerbates α-synuclein pathology and related toxicity independent of amyloid

  2020cites this paper
• Interaction between APOE genotype and diabetes in cognitive decline

  2020cites this paper
• Reduced Influence of apoE on Aβ43 Aggregation and Reduced Vascular Aβ43 Toxicity as Compared with Aβ40 and Aβ42

  2020cites this paper
• Strategy or symptom: Semantic clustering and risk of Alzheimer’s disease-related impairment

  2020cites this paper
• The development and convergence of co-pathologies in Alzheimer's disease.

  2020cites this paper
• APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer’s disease: a systematic review

  2020cites this paper
• Tau and apolipoprotein E modulate cerebrovascular tight junction integrity independent of cerebral amyloid angiopathy in Alzheimer’s disease

  2020cites this paper
• Blood-brain barrier integrity in the pathogenesis of Alzheimer's disease.

  2020cites this paper
• Sex as a biological variable in the pathology and pharmacology of neurodegenerative and neurovascular diseases

  2019cites this paper
• APOE 4-mediated amyloid-b pathology depends on its neuronal receptor LRP 1

  2019cites this paper
• Selective loss of cortical endothelial tight junction proteins during Alzheimer’s disease progression

  2019cites this paper
• APOE4-mediated amyloid-&bgr; pathology depends on its neuronal receptor LRP1

  2019cites this paper
• APOE ɛ4/ɛ4 Is Associated with Aberrant Motor Behavior Through Both Lewy Body and Cerebral Amyloid Angiopathy Pathology in High Alzheimer’s Disease Pathological Load

  2019cites this paper
• Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies

  2019cites this paper
• Clinical and genetic heterogeneity in young onset sporadic Alzheimer's disease

  2019cites this paper
• Evaluation of Associations of Alzheimer’s Disease Risk Variants that Are Highly Expressed in Microglia with Neuropathological Outcome Measures

  2019cites this paper
• Sex differences in mixed neuropathologies in community-dwelling older adults.

  2019cites this paper
• Sex differences in Alzheimer's disease: Understanding the molecular impact.

  2019cites this paper
• The Roles of Apolipoprotein E, Lipids, and Glucose in the Pathogenesis of Alzheimer's Disease.

  2019cites this paper
• Sex Differences in the Genetic Architecture of Alzheimer’s Disease

  2019cites this paper
• Sex differences in Alzheimer disease — the gateway to precision medicine

  2018cites this paper
• The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer’s disease in individuals with Down syndrome

  2018cites this paper
• Patterns and severity of vascular amyloid in Alzheimer’s disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer’s disease

  2018cites this paper
• Aβ propagation and strains: Implications for the phenotypic diversity in Alzheimer's disease.

  2018cites this paper
• An autopsy case of amyloid β-related angiitis with cognitive impairment, multiple infarcts and subcortical hemorrhage

  2018cites this paper
• The anatomic distribution and expression of matricellular proteins in the cerebral vasculature of Alzheimer's Disease subjects

  2018cites this paper
• APOE ε2 is associated with increased tau pathology in primary tauopathy

  2018cites this paper
• Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism

  2018cites this paper
• Peripheral Inflammation, Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction

  2017cites this paper
• EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer’s disease[S]

  2017cites this paper
• ApoE influences regional white-matter axonal density loss in Alzheimer's disease

  2017cites this paper
• Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer’s Disease

  2017cites this paper
• Calpain Activation in Alzheimer's Model Mice Is an Artifact of APP and Presenilin Overexpression

  2016cites this paper
• Apolipoprotein E as a Therapeutic Target in Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence

  2016cites this paper
• Systems proteomic analysis reveals that clusterin and tissue inhibitor of metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy

  2016cites this paper
• Cerebral amyloid angiopathy in a young man with a history of traumatic brain injury: a case report and review of the literature

  2016cites this paper